ASLAN Pharmaceuticals Limited (ASLN)
NASDAQ: ASLN · IEX Real-Time Price · USD
0.281
-0.019 (-6.33%)
At close: Jul 2, 2024, 4:00 PM
0.284
+0.003 (1.03%)
After-hours: Jul 2, 2024, 7:33 PM EDT

ASLAN Pharmaceuticals Statistics

Total Valuation

ASLN has a market cap or net worth of $6.36 million. The enterprise value is $14.63 million.

Market Cap 6.36M
Enterprise Value 14.63M

Important Dates

The next estimated earnings date is Friday, August 9, 2024, before market open.

Earnings Date Aug 9, 2024
Ex-Dividend Date n/a

Share Statistics

ASLN has 22.63 million shares outstanding.

Shares Outstanding 22.63M
Owned by Insiders (%) 0.14%
Owned by Institutions (%) 13.21%
Float n/a

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.53
Forward PS n/a
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 1.22
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.05

Current Ratio 1.05
Quick Ratio n/a
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -7.90

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -96.30%
Return on Capital (ROIC) -401.40%
Revenue Per Employee $342,857
Profits Per Employee -$1.00M
Employee Count 35
Asset Turnover 0.33
Inventory Turnover n/a

Taxes

In the past 12 months, ASLN has paid $126,074 in taxes.

Income Tax 126,074
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -92.28% in the last 52 weeks. The beta is 1.44, so ASLN's price volatility has been higher than the market average.

Beta (5Y) 1.44
52-Week Price Change -92.28%
50-Day Moving Average 0.41
200-Day Moving Average 0.74
Relative Strength Index (RSI) 28.32
Average Volume (20 Days) 179,813

Short Selling Information

Short Interest 269,900
Short Previous Month 297,376
Short % of Shares Out 1.20%
Short % of Float n/a
Short Ratio (days to cover) 1.57

Income Statement

In the last 12 months, ASLN had revenue of $12.00 million and -$35.03 million in losses. Loss per share was -$1.75.

Revenue 12.00M
Gross Profit 12.00M
Operating Income -34.92M
Pretax Income -34.90M
Net Income -35.03M
EBITDA n/a
EBIT -30.98M
Loss Per Share -$1.75
Full Income Statement

Balance Sheet

The company has $18.40 million in cash and $26.67 million in debt, giving a net cash position of -$8.27 million or -$0.37 per share.

Cash & Cash Equivalents 18.40M
Total Debt 26.67M
Net Cash -8.27M
Net Cash Per Share -$0.37
Equity (Book Value) -17.96M
Book Value Per Share -0.79
Working Capital 972,048
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -291.03% and -291.89%.

Gross Margin 100.00%
Operating Margin -291.03%
Pretax Margin -290.84%
Profit Margin -291.89%
EBITDA Margin n/a
EBIT Margin -258.15%
FCF Margin n/a

Dividends & Yields

ASLN does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -25.91%
Shareholder Yield -25.91%
Earnings Yield -550.90%
FCF Yield n/a

Analyst Forecast

The average price target for ASLN is $11.33, which is 3,932.03% higher than the current price. The consensus rating is "Strong Buy".

Price Target $11.33
Price Target Difference 3,932.03%
Analyst Consensus Strong Buy
Analyst Count 3
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on July 3, 2024. It was a reverse split with a ratio of 1:8.

Last Split Date Jul 3, 2024
Split Type Reverse
Split Ratio 1:8

Scores

ASLN has an Altman Z-Score of -26.22 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -26.22
Piotroski F-Score 1